The Patent Finder

Cytlimic Inc.

Also on record
Records under this name other than patents Cytlimic Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Cytlimic Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,537,626HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,304,997HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,526,388Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using the same, immunity inducer, and method for producing antigen-presenting cells
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,590,179Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,875,900Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,842,848Method for treating cancer by adminstering poly I:C and LAG-3-IgG fusion protein
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,491,204Composition comprising poly I:C and LAG-3-IGG fusion protein
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,291,718Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,759,518Medicine for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 12,448,413HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell
Formerly held
In force
 · USPTO record
In forceUSPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited